The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management in Clinical Practice curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including nonopioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will learn to recognize signs and symptoms of opioid dependence and abuse in order to optimally manage patients’ pain and medication use.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://ce.opioidanalgesicrems.com/RpcCEUI/rems/pdf/resources/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Charles E. Argoff, MD, FABPM

Professor of Neurology, Albany Medical College, Director, Comprehensive Pain Center, Albany Medical Center, Albany, NY

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine, Senior Vice-Chair, The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, Chief, Pain Medicine and Professor of Oncology, Roswell Park Cancer Institute, Buffalo, NY

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair, Department of Geriatrics, Philadelphia College of Osteopathic Medicine, Philadelphia, PA

Supported by Opioid Analgesic REMS Program Companies

Are you frequently challenged by the task of early and accurate diagnosis of Alzheimer’s disease (AD) as a PCP? Are you keen to the possibility of collaboration with secondary care specialists to optimize early recognition and management of AD? Are you up to date on the latest developments and clinical pearls of Alzheimer’s research in order to tailor patient-specific approaches for AD? This live virtual meeting will examine these challenges and provide effective strategies to meet them head on. 

This session will provide you with the latest information regarding the role of PCPs and their extended care team in early diagnosis of AD, effective methods to address racial and ethnic barriers to dementia-related care, and important clinical pearls to encourage collaboration among PCPs and secondary care specialists. In addition, learn the intricacies surrounding patient-specific management considerations, as well as the role of recently approved and emerging disease-modifying therapies for the management of AD.

Richard S. Isaacson, MD

Director, Center for Brain Health, Director, Alzheimer’s Prevention Clinic, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, FL, Adjunct Associate Professor of Neurology, Department of Neurology, Weill Cornell Medicine/NewYork-Presbyterian, New York City, NY

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine, Irvine, CA

Supported by Eisai

Sjögren’s disease (SjD) is one of the most prevalent, yet underdiagnosed autoimmune diseases. Most patients see numerous physicians in many different specialties and over months to years after symptoms first appear prior to getting an accurate diagnosis. Many are misdiagnosed with other disorders during this journey. Most patients with SjD present to their primary care provider (PCP) prior to seeing specialists, such as rheumatologists. PCPs could screen for and diagnose patients with SjD at a higher rate and expedite the time to an accurate diagnosis and hence provide much needed and effective treatments that can greatly improve their quality of life. Extraglandular complications affect most patients, proving that SjD is much more than “dry eyes and dry mouth.” PCPs are in a prime position to help identify patients with these complications and assist with proper management and referrals to the appropriate specialists. The participant in this PrimaryCareNOW course will learn the most up to date information about SjD, its diagnosis, and its treatment options. The participant will also have the opportunity to have a Q&A session with Dr. Thomas.

Donald E. Thomas, MD

Chair, National Board of Directors
of the Sjogren's Foundation

What do primary care providers need to know about psychopharmacology to treat major depressive disorder and anxiety? Join Dr. Jeffrey Rado as he reviews important concepts that can help you improve the care of your patients. 

Jeffrey Rado, MD, MPH, FAPA

Associate Professor, Northwestern Feinberg School of Medicine, Chicago, IL

In this session, the speaker will discuss some challenging diagnostic cases that primary care practitioners may face in their practice. These cases will feature interpretation of laboratory and imaging studies as well as encounters with rare diseases and conditions. You will learn which aspects of the history and physical exam are most useful to establish certain diagnoses, increase your awareness of certain uncommon but “can’t miss” diagnoses, and become familiar with clinical decision aids that improve diagnostic accuracy for certain common diagnoses.

Howard Libman, MD

Attending Physician, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Professor of Medicine, Emeritus, Harvard Medical School, Boston, MA

As part of its partnership with the Centers for Disease Control and Prevention’s Let’s Stop HIV Together campaign, Dr. Demetre Daskalakis, Director of the Division of HIV Prevention, will join Pri-Med faculty  Dr. Greg Hall, expert in African American health and healthcare, as they discuss strategies for stopping the HIV epidemic across all communities. In this session, you’ll explore the concept of HIV as a syndemic and how that framework can help you identify patients with risk factors for HIV. You’ll also learn the importance of applying a status neutral approach to HIV care to ensure effective treatment and prevention of HIV across all patient populations. You’ll also leave the session with information on the latest guidelines and recommendations, including the newly released guidelines on HIV prevention with PrEP.  It’s a can’t-miss educational opportunity for anyone looking for practical tools to help your patients and help end the HIV epidemic. 

Demetre C. Daskalakis, MD, MPH

Director, Division of HIV/AIDS Prevention (DHAP), Centers for Disease Control and Prevention , Atlanta, GA

Gregory L. Hall, MD

Associate Professor of Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH, Associate Professor of Internal Medicine, Northeast Ohio Medical University, Rootstown, OH, Assistant Clinical Professor in Medicine, Case Western Reserve University School of Medicine, Cleveland, OH

Nutrition research and recommendations are rapidly changing. Fill your toolbox with behavioral and food-driven action plans to answer your patients' toughest nutrition and lifestyle issues. Updated recommendations for nutrition advice for IBS, intermittent fasting, popular diets, food intolerances, and more will be answered.

Bethany Doerfler, MS, RDN

Senior Clinical Research Dietitian, Northwestern University, Feinberg School of Medicine, Adjunct Faculty, Marciella School of Nursing, Loyola University, Chicago, IL

Heart disease is the leading cause of death for women, and the pathophysiology, prevention strategies, screening, and treatments are often different from men. This session will discuss differences and similarities in heart disease between women and men and offer recommendations for prevention, evaluation, and treatment.

Karol E. Watson, MD, PhD

Professor of Medicine/Cardiology, Co-director, UCLA Program in Preventive Cardiology, Director, UCLA Barbra Streisand Women's Heart Health Program, David Geffen School of Medicine at UCLA

Fatty liver has emerged as a major health concern in the United States. It is now one of the leading causes of cirrhosis, risk factor for liver cancer and indication for liver transplantation. This session will help clinicians to understand the epidemiology and risk factors of fatty liver as well as how to tailor medical care in patients with underlying fatty liver disease.

Sammy Saab, MD, MPH, AGAF

Professor, Medicine and Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA, Head, Outcomes Research in Hepatology, David Geffen School of Medicine at UCLA, Los Angeles, CA

This session will provide an update on common skin disorders including diagnosis and management of papulosquamous disorders, medication reactions, skin infections, and melanocytic lesions.

Daniela Kroshinsky, MD, MPH

Associate Professor of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA